Literature DB >> 12607575

A scientist revisits the atrophy-hypertrophy complex: hepatic apoptosis and regeneration.

Dalliah M Black1, Kevin E Behrns.   

Abstract

In 1898, Cantlie demonstrated his deep insight into the AHC when he wrote. "It is theoretically possible to tie the vessels of one side at the gate of the liver...leaving the other side to do the work. That one-half of the liver can hypertrophy, so as to perform the function of the whole, is attested by pathological study...I commend this subject to all those who are working on the surgery of the liver; and I believe that if, in the hands of future observers, the statements I have made receive closer investigation, surgery of the liver will be advanced a step." More than 100 years later, his foresight is coming to fruition, but the understanding of the AHC remains rudimentary. Further insight into the cellular and molecular mechanisms that initiate hepatocyte replication after contralateral atrophy may allow the development of novel therapeutic treatments or adjuncts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12607575     DOI: 10.1016/s1055-3207(02)00031-5

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  7 in total

1.  Hypertrophy of the non-embolized liver after chemotherapy.

Authors:  Otmane Nafidi; Delphine Désy; Richard Létourneau; Jean Côté; Marylène Plasse; Franck Vandenbroucke; André Roy; Michel Dagenais; Réal W Lapointe
Journal:  HPB (Oxford)       Date:  2009-03       Impact factor: 3.647

2.  Acute iatrogenic Budd-Chiari syndrome following hepatectomy for hepatolithiasis: a report of two cases.

Authors:  Xue-Li Bai; Yi-Wen Chen; Qi Zhang; Long-Yun Ye; Yuan-Liang Xu; Liang Wang; Chun-Hui Cao; Shun-Liang Gao; Mohamed Adil Shah Khoodoruth; Bibi Zaina Ramjaun; Ai-Qiang Dong; Ting-Bo Liang
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

3.  Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions.

Authors:  David Li; David C Madoff
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

Review 4.  Current strategies to induce liver remnant hypertrophy before major liver resection.

Authors:  Celeste Del Basso; Martin Gaillard; Panagiotis Lainas; Stella Zervaki; Gabriel Perlemuter; Pierre Chagué; Laurence Rocher; Cosmin Sebastian Voican; Ibrahim Dagher; Hadrien Tranchart
Journal:  World J Hepatol       Date:  2021-11-27

5.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03

6.  Volume change and liver parenchymal signal intensity in Gd-EOB-DTPA-enhanced magnetic resonance imaging after portal vein embolization prior to hepatectomy.

Authors:  Ayako Akiba; Satoru Murata; Takahiko Mine; Shiro Onozawa; Tetsuro Sekine; Yasuo Amano; Youichi Kawano; Eiji Uchida; Shin-ichiro Kumita
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

7.  Subtotal (segment II-VIII) hepatectomy for bilateral diffuse hepatolithiasis with compensatory caudate lobe hypertrophy: a report of two cases.

Authors:  Wei Wang; ZiJie Zhang; Jian Wang
Journal:  BMC Gastroenterol       Date:  2020-10-20       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.